CD47-targeted immunotherapy unleashes antitumour immunity in Epstein-Barr virus-associated gastric cancer

被引:8
作者
Duan, Yantao [1 ,2 ]
Li, Shun [3 ]
Huang, Binhao [1 ,2 ]
Dou, Yi [1 ,2 ]
Kong, Pengfei [1 ,2 ]
Kang, Wei [4 ]
Xu, Dazhi [1 ,2 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Surg, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
[3] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Guangzhou 510060, Peoples R China
[4] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong 999077, Peoples R China
基金
中国国家自然科学基金;
关键词
CD47; Immunotherapy; Macrophage; Phagocytosis; Antitumour immunity; EBVaGC; TUMOR-ASSOCIATED MACROPHAGES; EXPRESSION; ANTIBODY; RECOGNITION; SURVIVAL; PROTEIN; TARGET; PD-L1; CELLS; CD47;
D O I
10.1016/j.clim.2023.109238
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aims of this study were to enhance the antitumour immunity in Epstein-Barr virus-associated gastric cancer (EBVaGC). We performed RNA-seq analysis to compare the differential expression genes between EBVaGC and EBV-negative gastric cancer (EBVnGC) patients. The expression levels of CD68, CD163 and CD47 were analyzed by immunohistochemistry. Different subsets of macrophages were investigated by a coincubation model. The effects of CD47 blockade were also detected. The expression levels of CD68, CD163 and CD47 were significantly higher in EBVaGC, and were associated with poor prognoses. Macrophages coincubated with EBV+ AGS cells tended to be immunosuppressed, which could be reversed by CD47 deficiency or blocking CD47. EBV resulted in cGAS-STING pathway activation, which stimulated CD47 expression and inhibited macrophage phagocytosis. Anti-CD47 therapy activated cGAS-STING signaling, which was responsible for production of IFN-beta, resulting in activation of antitumour immunity. Our results provide a promising new strategy for CD47-targeted immunotherapy in EBVaGC.
引用
收藏
页数:11
相关论文
共 48 条
[1]   CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells [J].
Abe, Hiroyuki ;
Saito, Ruri ;
Ichimura, Takashi ;
Iwasaki, Akiko ;
Yamazawa, Sho ;
Shinozaki-Ushiku, Aya ;
Morikawa, Teppei ;
Ushiku, Tetsuo ;
Yamashita, Hiroharu ;
Seto, Yasuyuki ;
Fukayama, Masashi .
VIRCHOWS ARCHIV, 2018, 472 (04) :643-651
[2]   Comprehensive molecular characterization of gastric adenocarcinoma [J].
Bass, Adam J. ;
Thorsson, Vesteinn ;
Shmulevich, Ilya ;
Reynolds, Sheila M. ;
Miller, Michael ;
Bernard, Brady ;
Hinoue, Toshinori ;
Laird, Peter W. ;
Curtis, Christina ;
Shen, Hui ;
Weisenberger, Daniel J. ;
Schultz, Nikolaus ;
Shen, Ronglai ;
Weinhold, Nils ;
Keiser, David P. ;
Bowlby, Reanne ;
Sipahimalani, Payal ;
Cherniack, Andrew D. ;
Getz, Gad ;
Liu, Yingchun ;
Noble, Michael S. ;
Pedamallu, Chandra ;
Sougnez, Carrie ;
Taylor-Weiner, Amaro ;
Akbani, Rehan ;
Lee, Ju-Seog ;
Liu, Wenbin ;
Mills, Gordon B. ;
Yang, Da ;
Zhang, Wei ;
Pantazi, Angeliki ;
Parfenov, Michael ;
Gulley, Margaret ;
Piazuelo, M. Blanca ;
Schneider, Barbara G. ;
Kim, Jihun ;
Boussioutas, Alex ;
Sheth, Margi ;
Demchok, John A. ;
Rabkin, Charles S. ;
Willis, Joseph E. ;
Ng, Sam ;
Garman, Katherine ;
Beer, David G. ;
Pennathur, Arjun ;
Raphael, Benjamin J. ;
Wu, Hsin-Ta ;
Odze, Robert ;
Kim, Hark K. ;
Bowen, Jay .
NATURE, 2014, 513 (7517) :202-209
[3]   The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies [J].
Bingle, L ;
Brown, NJ ;
Lewis, CE .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :254-265
[4]   Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations [J].
Boger, C. ;
Kruger, S. ;
Behrens, H. M. ;
Bock, S. ;
Haag, J. ;
Kalthoff, H. ;
Rocken, C. .
ANNALS OF ONCOLOGY, 2017, 28 (05) :1005-1014
[5]   Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer [J].
Cao, Xu ;
Li, Bolei ;
Chen, Jing ;
Dang, Jessica ;
Chen, Siqi ;
Gunes, E. Gulsen ;
Xu, Bo ;
Tian, Lei ;
Muend, Sabina ;
Raoof, Mustafa ;
Querfeld, Christiane ;
Yu, Jianhua ;
Rosen, Steven T. ;
Wang, Yingyu ;
Feng, Mingye .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (03)
[6]   Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma [J].
Chen, Dongjiang ;
Le, Son B. ;
Hutchinson, Tarun E. ;
Calinescu, Anda-Alexandra ;
Sebastian, Mathew ;
Jin, Dan ;
Liu, Tianyi ;
Ghiaseddin, Ashley ;
Rahman, Maryam ;
Tran, David D. .
JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (08)
[7]   Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy [J].
Chen, Huanpeng ;
Yang, Yuying ;
Deng, Yuqing ;
Wei, Fengjiao ;
Zhao, Qingyu ;
Liu, Yongqi ;
Liu, Zhonghua ;
Yu, Bolan ;
Huang, Zhaofeng .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
[8]   The cGAS-STING pathway as a therapeutic target in inflammatory diseases [J].
Decout, Alexiane ;
Katz, Jason D. ;
Venkatraman, Shankar ;
Ablasser, Andrea .
NATURE REVIEWS IMMUNOLOGY, 2021, 21 (09) :548-569
[9]   Macrophages as regulators of tumour immunity and immunotherapy [J].
DeNardo, David G. ;
Ruffell, Brian .
NATURE REVIEWS IMMUNOLOGY, 2019, 19 (06) :369-382
[10]   The cGAS-STING pathway drives type I IFN immunopathology in COVID-19 [J].
Di Domizio, Jeremy ;
Gulen, Muhammet F. ;
Saidoune, Fanny ;
Thacker, Vivek V. ;
Yatim, Ahmad ;
Sharma, Kunal ;
Nass, Theo ;
Guenova, Emmanuella ;
Schaller, Martin ;
Conrad, Curdin ;
Goepfert, Christine ;
de Leval, Laurence ;
von Garnier, Christophe ;
Berezowska, Sabina ;
Dubois, Anaelle ;
Gilliet, Michel ;
Ablasser, Andrea .
NATURE, 2022, 603 (7899) :145-+